Cargando…
Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517860/ https://www.ncbi.nlm.nih.gov/pubmed/37746275 http://dx.doi.org/10.3389/fonc.2023.1277542 |
| _version_ | 1785109388271288320 |
|---|---|
| author | Al-Rajabi, Taiseer Naidoo, Jarushka Zhang, Jun |
| author_facet | Al-Rajabi, Taiseer Naidoo, Jarushka Zhang, Jun |
| author_sort | Al-Rajabi, Taiseer |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10517860 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105178602023-09-24 Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer Al-Rajabi, Taiseer Naidoo, Jarushka Zhang, Jun Front Oncol Oncology Frontiers Media S.A. 2023-09-08 /pmc/articles/PMC10517860/ /pubmed/37746275 http://dx.doi.org/10.3389/fonc.2023.1277542 Text en Copyright © 2023 Al-Rajabi, Naidoo and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Al-Rajabi, Taiseer Naidoo, Jarushka Zhang, Jun Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| title | Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| title_full | Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| title_fullStr | Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| title_full_unstemmed | Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| title_short | Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| title_sort | editorial: optimizing outcomes and addressing adversities of immunotherapy in lung cancer |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517860/ https://www.ncbi.nlm.nih.gov/pubmed/37746275 http://dx.doi.org/10.3389/fonc.2023.1277542 |
| work_keys_str_mv | AT alrajabitaiseer editorialoptimizingoutcomesandaddressingadversitiesofimmunotherapyinlungcancer AT naidoojarushka editorialoptimizingoutcomesandaddressingadversitiesofimmunotherapyinlungcancer AT zhangjun editorialoptimizingoutcomesandaddressingadversitiesofimmunotherapyinlungcancer |